N-Ethylhexedrone was patented from the German pharmaceutical company Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[one] The cognitive outcomes of mephedrone is often damaged down into quite a few